Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) with real-time-image gated spot-scanning system for non-metastatic prostate cancer (T1c-T4N0M0) - Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) for non-metastatic prostate cancer (T1c-T4N0M0)

Kyoto Prefectural University of Medicine Department of Radiology0 sites180 target enrollmentFebruary 1, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 1, 2022

End Date

December 31, 2030

Last Updated

2 years ago

Study Type

Interventional

Sex

Male

Sponsor

Kyoto Prefectural University of Medicine Department of Radiology

•Prior radiotherapy to the pelvic area Prior prostate cancer therapy such as: prostatectomy, radiation therapy, chemotherapy or high intensity focused ultrasound (HIFU) . Patients with previous Transurethral Resection of the Prostate (TURP) performed for urinary retention may be included. Second invasive malignancy (except of carcinoma in situ, treated by optimal therapy) if not controlled within last 5 years. It is clinically difficult to place fiducial markers into prostate. There is uncontrollable inflammation in pelvic lesion or inflammatory systemic disease. It is difficult to provide study\-specific informed consent prior to study entry.